Mode
Text Size
Log in / Sign up
N/A Completed N=920 Treatment

Safety and Efficacy of the Accent Magnetic Resonance Imaging™ (MRI) Pacemaker and Tendril MRI™ Lead

Adverse Effect of MRI on an Implanted Pacemaker Lead · Adverse Effect of MRI on an Implanted Pacemaker
Source: ClinicalTrials.gov NCT01576016 ↗
Enrolled (actual)
920
Serious AEs
6.0%
Results posted
Nov 2020
Primary outcomePrimary: Freedom From Right Atrial (RA) Lead-related Complications in the Acute Period — 97.2 percentage of subjects

Summary

The MRI Study is a prospective, multi-center, clinical study designed to evaluate the safety and efficacy of the Accent MRI™ System in a patient population indicated for implant of a pacemaker within and outside of the MRI environment.

Outcome Measures

OutcomeResultp-value
PRIMARY
Freedom From Right Atrial (RA) Lead-related Complications in the Acute Period
97.2 —
PRIMARY
Freedom From Right Ventricular (RV) Lead-related Complications in the Acute Time Period
98.45 —
PRIMARY
Freedom From RA Related Complications in the Chronic Period
98.82 —
PRIMARY
Freedom From Right Ventricular Lead Related Complications in the Chronic Period
100 —
PRIMARY
Freedom From MRI Scan-related Complications
100 —
PRIMARY
Change in Atrial Capture Threshold From Pre to Post MRI Scan
100 —
PRIMARY
Change in Ventricular Capture Threshold Pre to Post MRI Scan
100 —
PRIMARY
Change in Atrial Sense Amplitude
92.56 —
PRIMARY
Change in Ventricular Sense Amplitude
97.76 —
SECONDARY
Freedom From System-related Complications
94.64 —
SECONDARY
Atrial Capture Threshold at the MRI Visit
100.00 —
SECONDARY
Ventricular Capture Threshold at the MRI Visit
100.00 —

Eligibility Criteria

Inclusion Criteria

Eligible patients will meet all of the following:

  • Have an approved indication per American College of Cardiology (ACC)/American Heart Association (AHA)/Heart Rhythm Society (HRS) guidelines for implantation of a pacemaker
  • Will receive a new pacemaker and lead
  • Be willing to undergo an elective MRI scan without sedation
  • Be able to provide informed consent for study participation (legal guardian is NOT acceptable)
  • Be willing and able to comply with the prescribed follow-up tests and schedule of evaluations
  • Is not contraindicated for an MRI scan (per the pre-MRI safety screening form)

Exclusion Criteria

Patients will be excluded if they meet any of the following:

  • Are medically indicated for an MRI scan at the time of enrollment
  • Have an existing pacemaker or implantable cardioverter defibrillator (ICD). A new pacemaker and lead is required for enrollment
  • Have an existing active/inactive implanted medical device, e.g., neurostimulator, infusion pump, etc.
  • Have a non-MRI compatible device or material implanted (e.g., intracranial aneurysm clip, non-MRI compatible devices or material, metals or alloys, etc.)
  • Have a lead extender or adaptor
  • Be unable to fit in MRI bore; will come into contact with the magnet façade inside the MRI bore.
  • Have a prosthetic tricuspid heart valve
  • Are currently participating in a clinical investigation that includes an active treatment arm
  • Are allergic to dexamethasone sodium phosphate (DSP)
  • Are pregnant or planning to become pregnant during the duration of the study
  • Have a life expectancy of less than 12 months due to any condition
  • Patients with exclusion criteria required by local law (e.g., age)
  • Are unable to comply with the follow up schedule
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01576016). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search